Abnormal bleeding or bruising associated with antieplieptic treatment.
Besag
Frank M C
FM
D000927:Anticonvulsants / Q000009:adverse effects*; D001792:Blood Platelets / Q000187:drug effects; D003288:Contusions / Q000097:blood / Q000139:chemically induced*; D004844:Epistaxis / Q000139:chemically induced; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives; D006470:Hemorrhage / Q000097:blood / Q000139:chemically induced*; D006801:Humans; D018696:Neuroprotective Agents / Q000009:adverse effects*; D018570:Risk Assessment; D000077236:Topiramate; D014635:Valproic Acid / Q000009:adverse effects
D000927:Anticonvulsants; D018696:Neuroprotective Agents; D000077236:Topiramate; D005632:Fructose; D014635:Valproic Acid